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Apoptotic cell death can occur by two different pathways. Type 1 is initiated by the activation of death receptors (Fas, TNF-receptor-
family) on the plasma membrane followed by activation of caspase 8. Type 2 involves changes in mitochondrial integrity initiated by various
effectors like Ca2 +, reactive oxygen species (ROS), Bax, or ceramide, leading to the release of cytochrome c and activation of caspase 9. The
release of cytochrome c is followed by a decrease of the mitochondrial membrane potential DWm. Recent publications have demonstrated,
however, that induction of apoptosis by various effectors involves primarily a transient increase of DWm for unknown reason. Here we
propose a new mechanism for the increased DWm based on experiments on the allosteric ATP-inhibition of cytochrome c oxidase at high
matrix ATP/ADP ratios, which was concluded to maintain low levels of DWm in vivo under relaxed conditions. This regulatory mechanism is
based on the potential-dependency of the ATP synthase, which has maximal activity at DWm = 100–120 mV. The mechanism is turned off
either through calcium-activated dephosphorylation of cytochrome c oxidase or by 3,5-diiodo-L-thyronine, palmitate, and probably other so
far unknown effectors. Consequently, energy metabolism changes to an excited state. We propose that this change causes an increase in DWm,
a condition for the formation of ROS and induction of apoptosis.
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protein dephosphorylation; cAMP-dependent phosphorylation1. Mammalian cytochrome c oxidase
Prokaryotic cytochrome c oxidase consists of three to
four subunits. In contrast, the mammalian enzyme is com-
posed of 13 subunits. The three largest subunits (I–III),
encoded by mitochondrial DNA, are homologous to sub-
units I–III from bacteria. The 10 additional subunits are
encoded by the nuclear genome and occur as tissue-specific
isoforms [1]. In addition to the muscle- and non-muscle-
specific expression of subunits VIa, VIIa and VIII, a lung-
specific isoform was identified for subunit IV (IV-2) [2].
Recently, an isoform of subunit VIb was found to be
expressed exclusively in mammalian testes [3].
The structures of the three catalytic centers of the
bacterial and mammalian enzymes, however, are almost0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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two-copper center CuA, the binding site for cytochrome c.
Heme a and the oxygen binding heme a3/CuB centers are
located in subunit I. Accordingly, both enzymes have the
same catalytic functions [6,7]: (1) transfer of electrons from
ferrocytochrome c to oxygen, accompanied by the vectorial
uptake of protons for the formation of water, forming a
membrane potential DWm, and (2) outward translocation of
protons, associated with the formation of a pH gradient and
DWm (predominantly). The catalytic properties of the
enzymes from Paracoccus denitrificans and bovine heart
are similar, when measured with the isolated enzymes under
standard conditions [8,9]. Under more physiological con-
ditions, however, large differences in the catalytic activities
are found between the two. The differences in electron
transport and proton pumping are related to the additional
subunits of the mammalian enzyme. A decrease of the H+/
e stoichiometry (from 1.0 to 0.5) of the heart-type enzyme
(subunit VIaH) at high matrix ATP/ADP-ratios [10], and of
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of palmitate [11], was found. The mechanism of proton
pumping in cytochrome c oxidase is still debated [12], and
different views exist for the mammalian [13] and bacterial
enzymes [14]. Therefore, mechanisms on how the H+/e
stoichiometry can be modulated remain to be elucidated.2. Regulation of mitochondrial respiration by cyto-
chrome c oxidase
The rate and efficiency of electron transport in the
respiratory chain of mammalian mitochondria must be con-
trolled according to the cellular needs for ATP and heat
production. Applying ‘‘metabolic control analysis’’ to iso-
lated mitochondria, a ‘‘control strength’’ of 0.15–0.2 was
determined for cytochrome c oxidase, indicating little rate-
limiting control by the terminal enzyme of the respiratory
chain [15]. When the same method is applied to cultured
cells, however, cytochrome c oxidase was shown to repre-
sent the rate-limiting step of the mitochondrial electron
transport chain [16]. The control of respiration by the
utilization of ATP is named ‘‘respiratory control’’, and is
explained by the chemiosmotic theory [17]: the free energy
of substrate oxidation is partly stored in a proton gradient
across the inner mitochondrial membrane (mainly DWm). At
high ATP utilization the rate of ATP synthase, driven by the
consumption of DWm, increases, resulting in a decrease of
DWm. A lowered DWm stimulates respiration because the
three proton pumps of the respiratory chain (complexes
I = NADH dehydrogenase, III = cytochrome c reductase,
and IV= cytochrome c oxidase) are inhibited only at high
DWm (180–200 mV).
A second mechanism of respiratory control was discov-
ered based on inhibition of cytochrome c oxidase at high
intramitochondrial ATP/ADP ratios [18,19]. This allosteric
ATP-inhibition of cytochrome c oxidase, verified by sig-
moidal kinetics with a Hill coefficient of 2 [18], is inde-
pendent of DWm, and due to high-affinity binding of ATP
(or ADP) to the matrix domain of subunit IV ([20], see also
Ref. [2]). At low ATP/ADP ratios in the mitochondrial
matrix (half-maximal inhibition at ATP/ADP= 28), the en-
zyme becomes maximally active in a non-allosteric manner
(hyperbolic kinetics). We postulated that in vivo the ATP-
inhibition normally keeps mitochondrial membrane poten-
tial low (DWm= 80–140 mV), due to feedback control by
ATP [21], based on saturation and maximal rates of ATP
synthesis by the ATP synthase at DWm = 100–120 mV [22].
The ATP-inhibition, however, is only effective when cyto-
chrome c oxidase is phosphorylated, perhaps at Ser441 of
subunit I of the bovine enzyme [21]. In mitochondria the
phosphate group can be reversibly cleaved off by a calcium-
activated protein phosphatase in the intermembrane space
[23,24]. When cytochrome c oxidase is dephosphorylated,
and the control of respiration (and thus of DWm) by the ATP/
ADP ratio is abolished, DWm is controlled by the potential-dependency of the three proton pumps, leading to inhibition
of respiration only at high DWm values (140–200 mV).
In addition to dephosphorylation of cytochrome c
oxidase, the allosteric ATP-inhibition is switched off by
3,5-diiodo-L-thyronine [25], which is produced in cells
from triiodo-L-thyronine by a deiodinase. Furthermore, free
palmitate was found to specifically switch off the allosteric
ATP-inhibition of reconstituted bovine heart cytochrome c
oxidase with half-maximal effect at 0.3 AM (Shahla
Hammerschmidt, Diplomarbeit, Fachbereich Chemie, Phil-
ipps-Universita¨t Marburg, 1998). From these results a
molecular–physiological hypothesis was proposed, sug-
gesting, in living cells, a reversible switch from relaxed
to excited state of energy metabolism by stress, with the
consequence of hyperpolarization of DWm and reactive
oxygen species (ROS) production (Fig. 1) [21,26–28].
The regulation of energy metabolism by the allosteric
ATP-inhibition of cytochrome c oxidase was recently
reviewed [29].
In the following sections, important cellular responses
that involve an increased mitochondrial membrane potential
are reviewed. These findings are discussed in the light of
cytochrome c oxidase regulation, which might provide a
molecular mechanism to explain changes in DWm.3. Cellular stress
Cellular stress is caused by multiple factors including
injury, inflammation, hypoxia, hormones, high concentra-
tions of metabolites or xenobiotics, and excessive muscle
work. ‘‘Metabolic stress’’ is created when the activity of a
cell is stimulated, and could result in ‘‘oxidative stress’’
when ROS are produced intracellularly, particularly in
mitochondria which participate in type 2 apoptosis [30–
32]. Furthermore, xenobiotics and exogenous oxidants can
generate ‘‘cytotoxic stress’’ that threatens survival of the
cell. ROS represent the reaction products of various oxi-
dases and are produced in peroxisomes, endoplasmatic
reticulum and plasma membrane of lymphocytes, where
they participate in eliminating bacteria. Small amounts of
ROS are probably produced at the plasma membrane of all
cells, where they participate as ‘‘second messenger’’ in
receptor-mediated signal transduction [33]. Deleterious
amounts of ROS are produced at the respiratory chain in
mitochondria by transfer of an unpaired electron from
ubisemiquinone (at complexes I and/or III) to dioxygen
leading to the production of the superoxide radical anion
O2
 S. The superoxide radical anion is only produced at
higher membrane potentials (DWm>140 mV) [34,35], but
not in mitochondria of resting cells, which posses a low
DWm. The regulation of the DWm level in living cells,
however, is not completely understood.
Previous studies demonstrated a decrease of the mito-
chondrial membrane potential DWm after induction of type 2
apoptosis by various compounds in different cells, including
Fig. 1. The relaxed state of cellular energy metabolism, characterized by a low mitochondrial membrane potential DWm (80–140 mV), is proposed to be based
on feedback inhibition of cytochrome c oxidase (COX-P, respiration) by high matrix ATP/ADP ratios, which are produced by the ATP synthase. Oxidative
stress in mitochondria is proposed to originate from turning off the allosteric ATP-inhibition of cytochrome c oxidase either by calcium-activated
dephosphorylation (COX), induced by hormones, agonists and anaerobiosis, or without dephosphorylation (COX(P)) by 3,5-diiodo-L-thyronine (T2) and
palmitate. As a consequence, DWm increases to high values (150–220 mV), because respiration is no longer controlled by the ATP/ADP ratio but by DWm. At
high DWm values (>140 mV), ROS are produced which could induce apoptosis and degenerative diseases. High DWm values also decrease the H
+/e
stoichiometry of cytochrome c oxidase, thus increasing thermogenesis and the rate of oxidative phosphorylation under stress [29].
B. Kadenbach et al. / Biochimica et Biophysica Acta 1655 (2004) 400–408402the glutamate cytotoxicity in neurons. In contrast, more
recent publications indicate a transient increase of DWm
(hyperpolarization) during apoptotic cell death. Absolute
values of DWm were rarely determined in living cells,
because most fluorescence dyes only indicate a relativeincrease or decrease of DWm. Wan et al. [36] determined
absolute DWm values in perfused rat hearts ranging from
100 to 140 mV, depending on the work load and the
supplied substrate. These low values obtained from intact
organs contrast with the high DWm values of 180–220 mV,
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cytochrome c oxidase [37]. In a recent report, Zhang et al.
[38] verified the low DWm values in intact cells with a newly
developed method and measured 105F 0.9 mV in cultured
fibroblasts and 81F 0.7 mV in neuroblastoma cells.4. Hyperpolarization of DWm during apoptosis
Two pathways of programmed cell death are known. Type
1 is initiated from the cell surface death receptors (Fas, TNF-
family receptors) and involves activation of caspase-8, a
cysteine protease cleaving at the C-side of aspartate [31].
Type 2 is triggered by changes of mitochondrial integrity and
involves release of cytochrome c into the cytosol, which
activates procaspase-9 to caspase–9 via a complex with
Apaf-1 and dATP (apoptosome). Subsequently the mito-
chondrial permeability transition pore is formed with conse-
quent decrease of DWm. The mitochondrial pathway can be
initiated by Ca2 +, Bax, ROS, p53, or ceramides, and is
inhibited by Bcl-2 or Bcl-xL [30,32,39]. The death receptor-
initiated apoptosis (type 1) can also lead to release of
cytochrome c via cleavage of Bid to truncated Bid (tBid)
by caspase–8. Recently, the release of cytochrome c was
explained by formation of a pore in the outer mitochondrial
membrane, composed of tBid/Bax and cardiolipin [40]. This
release of cytochrome c would not involve opening of the
mitochondrial permeability transition pore [41] or decrease
of DWm [32,42]. In contrast to the observed depolarization of
DWm in previous studies, the following more recent publi-
cations describe a primary and transient increase of DWm
(hyperpolarization) after induction of apoptosis by various
stress parameters. The possible involvement of cytochrome c
oxidase in the hyperpolarization of DWm during the apopto-
tic pathway, via turning off the allosteric ATP-inhibition, will
be discussed. Other mechanisms regulating DWm have been
recently reviewed [29].
4.1. Transient increase of DWm in apoptotic cell death
A transient increase of DWm after induction of apoptosis
in human Jurkat T cells by Anti-Fas antibody, staurosporine,
or IL-3 depletion of FL5.12 cells was first described by
Vander Heiden et al. [43]. Subsequently, a transient increase
of DWm in different cells after induction of apoptosis by a
variety of compounds has been reported in many publica-
tions, for example the cytostatica cisplatin [44], thymitaq
[45], cyclic hydroxamates [46], and camptothecin [47], by
the organophosphorus compounds parathion, tri-o-tolyl-
phoshate, and triphenylphosphit [48], and by areca nut
and arecoline [49]. Furthermore, oxidized low density
lipoprotein (LDL) [50], overexpression of transglutaminase
[51], and stimulation of peripheral blood lymphocytes with
IL-3, IL-10, TGF-beta(1), IFN-gamma or co-stimulation
with CD3/CD28 [52] lead to transient hyperpolarization of
DWm. Finally, general stress factors like H2O2 [53], alkalo-sis (high pH in the medium) [54], irradiation with a Helium-
Neon laser [55], and gamma-irradiation [56] caused a
transient hyperpolarization of DWm, followed by apoptosis.
The mechanisms leading to hyperpolarization of DWm are
unknown. We propose a decrease of DWm due to abolition
of the allosteric ATP-inhibition of cytochrome c oxidase,
either directly via binding of some of the above affectors
(similarly as observed for 3,5-diiodo-L-thyronine and pal-
mitate) or indirectly by dephosphorylation of cytochrome c
oxidase via a calcium-activated protein phosphatase. While
control of respiration by the ATP/ADP ratio via phosphor-
ylated cytochrome c oxidase is proposed to keep DWm low,
the dephosphorylation of the enzyme causes an increase in
respiration, because now proton pump activity is only
limited by high values of DWm (when substrate supply is
high and DWm consumption low).
4.2. Apoptosis via calcium-activated increase of DWm
Induction of apoptosis in Jurkat T-cells by the common
fungicide tributyltin was preceded by an immediate increase
of cytosolic [Ca2 +] accompanied by hyperpolarization of
DWm (maximal at 1 min after addition), followed by loss of
DWm, release of mitochondrial cytochrome c and activation
of type 2 caspases [57]. During ischemia in heart and brain,
ATP is synthesized by glycolysis instead of oxidative
phosphorylation. The accumulation of lactic acid and de-
crease of pH result in inhibition of calcium pumps and
increase of cytosolic [Ca2 +] [58]. The glutamate cytotox-
icity in neurons is based on apoptosis via increased [Ca2 +]
and mitochondrial ROS production [59]. A decrease of
DWm by mitochondrial uncouplers prevented ROS forma-
tion and neuronal apoptosis [59,60], indicating that hyper-
polarization of DWm causes ROS production. Recently,
DWm was measured in hippocampal neurons after ische-
mia–reperfusion. Ischemia for 30 min decreased DWm, but
DWm increased after reoxygenation to hyperpolarizing val-
ues (200%). After prolonged ischemia for 90 min, DWm
values remained low and did not recover [61]. We hypoth-
esize that calcium accumulation during ischemia leads to
dephosphorylation of cytochrome c oxidase. After reperfu-
sion, DWm increases to hyperpolarizing values and ROS are
produced which, depending on the amount, initiate apopto-
sis. Prolonged ischemia leads to irreversible damage of
mitochondria (e.g. opening of the permeability transition
pore [41]) and cell death.
The ischemia–reperfusion injury in heart is generally
believed to be related to oxidative stress during reoxyge-
nation, which finally could lead to apoptotic cell death [62].
ROS formation in the heart might also involve transient
increase of DWm. Diazoxide, a mitochondrial KATP channel
opener, was found to prevent ATP depletion, loss of
cytochrome c, and stabilized DWm after ischemia–reperfu-
sion of cultured myocytes [63]. Recently, the decrease of
ROS production in isolated mitochondria from heart, brain
and liver through opening of the K(ATP) channel by
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demonstrated [65]. In isolated mitochondria, cytochrome c
oxidase is usually dephosphorylated [24], resulting in high
DWm and increased ROS formation. Thus, the protective
effect of diazoxide on ischemia–reperfusion injury could
be partly explained by decreasing highly elevated DWm
values through influx of K+ into mitochondria via the KATP
channel.
4.3. Thyroid hormones
Brain mitochondria from hypothyroid rats showed a
lower mitochondrial membrane potential DWm than those
of euthyroid rats [66], and hypothyroidism caused a de-
crease of H2O2 formation in rat heart mitochondria [67].
Thyroid hormones induced the formation of ROS and
subsequent apoptosis in cultured human lymphocytes, and
lymphocytes from patients with Graves’ disease (hyperthy-
roidism) exhibited spontaneous apoptosis [68]. After heart
ischemia–reperfusion, the rate and amount of H2O2 forma-
tion as well as the concentration of antioxidants were
greater in rats of hyperthyroid compared to euthyroid rats
[69]. Thyroid hormones increased the ‘‘oxidative stress’’ in
mouse heart as observed by peroxidation of lipids and
modification of mitochondrial DNA [70]. All these data
could be explained by the abolishing effect of thyroid
hormones on the allosteric ATP-inhibition of cytochrome
c oxidase [25], inducing consequently an increase of DWm,
which is accompanied by formation of ROS [34,35].
4.4. Palmitate induces apoptosis
Accumulation of long-chain fatty acids in the heart has
been proposed to play a role in the development of heart
failure and diabetic cardiopathy. It is also believed that free
fatty acids contribute to the pathogenesis of type 2 diabetes
in humans. In particular palmitate was shown to induce
apoptosis of cardiomyocytes [71], CHO cells [72], rat
pancreatic islet cells [73], microvascular cells, and retinal
pericytes [74]. Palmitate-induced programmed cell death
could occur by two different pathways: one is associated
with the production of ceramide and independent of ROS
formation [75]. The second pathway involves the produc-
tion of ROS in mitochondria [74], and could be prevented
by radical scavengers [72]. In embryonic chicken cardio-
myocytes, apoptosis was induced by palmitate but not by
oleate [76]. From ROS production, induced by palmitate in
microvascular cells and retinal pericytes from patients with
diabetes, it was concluded that ROS are involved in the
development of diabetic retinopathy [74]. The induction of
apoptosis in beta-islet cells of rat pancreas by both, palmi-
tate ( + oleate) or by high glucose (17 mM), was related to
oxidative stress [73]. These results are in accordance with
the abolition of allosteric ATP-inhibition of cytochrome c
oxidase by palmitate, resulting in increase of DWm and ROS
formation.4.5. High glucose-induced apoptosis in neurons
The association between oxidative stress and apoptosis is
important in the pathogenesis of diabetes-specific microvas-
cular diseases [77] as well as neurodegenerative diseases,
such as Alzheimer’s disease, Huntington’s disease, muscular
dystrophies, and in models of cerebral ischemia. Also
diabetic neuropathy is characterized by loss of neurons.
The process of apoptosis in primary dorsal root ganglion
neurons by high concentrations of glucose (45 mM) was
preceded by an intermediary hyperpolarization of DWm,
followed by depolarisation, ROS formation and activation
of caspase-3 and -9; and these effects could be prevented by
respiratory chain inhibitors (myxothiazol, thenoyltrifluoroa-
cetone) [78]. Similarly, in human neuronal cell line SH-
SY5Y, rat sensory neurons, and Schwann cells the induction
of ROS production by 20 mM glucose was preceded by
hyperpolarization of DWm [79].
In almost all regions of the brain, the presence of fatty
acid synthetase was demonstrated histochemically, which,
in contrast to liver, is not decreased during starvation [80].
The final product of fatty acid synthetase in animals is free
palmitate, in contrast to palmitoyl-CoA, the end product of
fatty acid synthesis in bacteria and plants. In addition to its
main function as energy-rich fuel, palmitate could represent
a second messenger of energy metabolism in animals.
We postulate that high glucose concentrations stimulate
fatty acid synthesis as a consequence of increased acetyl-
CoA and citrate levels in neurons, resulting in increased
concentrations of free palmitate, which is not consumed as
energy fuel in neurons. Free palmitate could turn off the
allosteric ATP-inhibition of cytochrome c oxidase, leading
to increased DWm values, the production of ROS, and
induction of apoptosis. Increased ROS production as a
consequence of elevated DWm values is generally accepted
to be a cause of diabetes-specific microvascular diseases,
but our view differs from that of Brownlee [77], who
suggests overproduction of electron donors by the TCA
cycle being the cause of increased DWm.
4.6. p53-induced apoptosis
The tumor suppressor p53 stimulates the transcription of
pro-apoptotic genes in certain cell types [81], and was
shown to translocate to the mitochondria of apoptosing cells
[82]. Overexpression of p53 in HeLa cells induced apoptotic
cell death. The signal cascade involved first increased O2
 S
production, followed by hyperpolarization of DWm and
increased H2O2 levels, and subsequent decrease of DWm.
p53-induced apoptosis was not associated with cytochrome
c release, but involved caspase activation and up-regulation
of Bax. Overexpression of Bcl-2 prevented the increase of
DWm but not the increase of O2
 S and H2O2 [83]. In
addition, the induction of apoptosis by camptothecin or
hypoxic stress in different cells was accompanied by trans-
location of p53 to mitochondria, and by an early increase of
hysica Acta 1655 (2004) 400–408
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 S
preceding the increase of DWm in HeLa cells [83] could
indicate two different ROS signals during induction of
apoptosis, one of which could originate outside of mito-
chondria (e.g. from plasma membrane NADH oxidase [33])
and initiates apoptosis, whereas the other originates from
mitochondria as a consequence of DWm hyperpolarization.
4.7. Fas-induced apoptosis
The delivery of signals through the cell surface death
receptor Fas or other receptors of the TNF (tumor necrosis
factor) family has emerged as a major pathway in the
elimination of unwanted cells under physiological and
disease conditions [85]. In human T-cell leukemia cells
(Jurkat cells) and peripheral blood lymphocytes, induction
of apoptosis by anti-Fas antibody was preceded by DWm
hyperpolarization and formation of ROS, which occurred
before externalization of phosphatidylserine in the plasma
membrane, activation of caspases, depolarisation of DWm,
and cell death [86]. In addition, anti-Fas antibodies caused
a release of endogenous NO from Jurkat cells in sufficient
amounts to inhibit cell respiration (cytochrome c oxidase
activity). As shown in Ref. [87], the increase of DWm is
generated from glycolytic ATP by reversal of the F1F0-
ATPase reaction. Rat cortical neurons and astrocytes re-
spond differently upon NO generated from its donor
DETA-NO. Astrocytes show an inhibition of cell respira-
tion, a subsequent increase in the rate of glycolysis as well
as a persistent mitochondrial hyperpolarization without
exhibiting apoptotic cell death, while neurons undergo
mitochondrial depolarization with increased apoptosis.
The increased DWm in astrocytes was prevented by inhib-
itors of the F1F0-ATPase and the adenine nucleotide
carrier, or by glucose deprivation [88], indicating that
hyperpolarization of DWm was based on hydrolysis of
glycolytic ATP.
Why is DWm generated from glycolytic ATP higher than
that produced by mitochondrial oxidative phosphorylation?
After inhibition of cytochrome c oxidase by NO, subsequent
generation of DWm is produced by the exchange of glyco-
lytic ATP4 for mitochondrial ADP3 and reversal of the
F1F0-ATPase reaction. We propose that DWm, no longer
controlled by allosteric ATP-inhibition of cytochrome c
oxidase, is limited only by the proton permeability of the
membrane, which increases exponentially above 140 mV
[89]. Therefore, at high glycolytic ATP/ADP ratios elevated
DWm values are produced, corresponding to the high values
obtained in isolated mitochondria, where the allosteric ATP-
inhibition is turned off [21].
4.8. Cancer cells
Cancer cells are generally more active than normal cells
in metabolic ROS generation and are constantly under
oxidative stress (for review see Ref. [90]). In addition,mitochondrial hyperpolarization is a shared feature of many
tumor cell lines [91]. One explanation for the increased
DWm in tumor cells could be the frequent occurrence of
somatic mutations in mitochondrial DNA (for review see
Ref. [92]). A defective synthesis of one of the thirteen
mtDNA-encoded protein subunits of the four mitochondrial
proton pumps of oxidative phosphorylation could impair
mitochondrial ATP synthesis with consequently increased
glycolytic ATP production. Similarly, in solid tumors the
lack of oxygen supply could stimulate glycolytic ATP
production. The glycolytic ATP would create DWm via
reversal of F1F0-ATPase but without feedback control by
the allosteric ATP-inhibition of cytochrome c oxidase,
resulting in increased DWm-values. This mechanism of
DWm increase, however, depends on additional factors, such
as sufficient glycolytic ATP production, and higher mito-
chondrial matrix pH to prevent binding of IF1, the F1F0-ATP
synthase inhibitor protein, which binds to F1 at low pH
thereby preventing ATP hydrolysis. It could be envisioned
that the nuclear-encoded components of the respiratory
chain complexes could still allow electron transfer from
NADH via ubisemiquinone to molecular oxygen thus form-
ing the superoxide radical anion O2
 S. An ‘‘injury’’ of the
respiratory machinery, resulting in compensatory increases
of glycolytic ATP production, was the basis of Warburg’s
[93] hypothesis on cancerogenesis originally proposed 70
years ago.
Another explanation for increased DWm values in cancer
cells could be turning off the allosteric ATP-inhibition by
calcium-activated dephosphorylation of cytochrome c oxi-
dase. Wojczak et al. [94] observed in Ehrlich ascites tumor
and Zajdela hepatoma cells an increase of cytosolic and
mitochondrial [Ca2 +] by glucose and deoxyglucose, paral-
leled by hyperpolarization of DWm and increased reduction
state of nicotine nucleotides. The authors suggested, how-
ever, that the inhibition of the F1F0-ATPase by calcium,
which is more pronounced in tumor cells than in normal
cells, caused the stimulation of DWm in tumor cells, in
addition to stimulation of DWm by the activation of mito-
chondrial dehydrogenases by calcium [95].5. Conclusion
Our review of the literature revealed no clear explana-
tion for the hyperpolarization of DWm after induction of
apoptosis by various parameters in different cell types,
followed by ROS production. We hypothesize that prevent-
ing the allosteric ATP-inhibition of cytochrome c oxidase
(by either calcium-activated dephosphorylation, 3,5-diiodo-
L-thyronin or palmitate) may contribute to hyperpolariza-
tion of DWm. Alternatively, the generation of high DWm
values from glycolytic ATP when the respiratory chain is
blocked could also explain some of the above observations.
The reversible switching of the control of respiration either
by the ATP/ADP ratio or by DWm, resulting in DWm values
B. Kadenbach et al. / Biochimica et Biophysica Acta 1655 (2004) 400–408406of 80–140 or 140–200 mV, respectively, could represent a
general principle of the control of energy metabolism in
animal cells. This hypothesis implies a reversible change
from a resting to an excited state of energy metabolism
with a higher rate of ATP synthesis (Fig. 1), but at the
expense of oxidative stress [21,26–29]. However, the
proposed mechanism for the control of DWm has not been
tested in intact cells so far. Therefore, the aim of this paper
is to encourage new investigations on the possible role of
the allosteric ATP-inhibition of cytochrome c oxidase in the
control of DWm in vivo, and thus in the progression of
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